Somnetics International, Inc. Launches Full-Feature Transcend Auto™ CPAP Device

Share Article

Auto-adjusting positive airway pressure (APAP) device features Transcend EZEX™ pressure relief technology on exhalation.

Transcend Auto received FDA clearance and is launched in the U.S. as the world's smallest, lightest most portable sleep apnea treatment for home and travel

Our objective is to design sleep apnea devices that meet the lifestyle needs of active patients

Somnetics International, Inc., the Minneapolis-based maker of Transcend® Sleep Apnea Therapy System™ received FDA clearance to market the new Transcend Auto™ full-feature auto-adjusting positive airway pressure (APAP) unit with Transcend EZEX™ pressure relief technology on exhalation. The Transcend Auto offers users diagnosed with sleep apnea the world’s smallest, lightest and most portable therapy device and accessories designed for use at home and for travel.

The new Transcend Auto automatically adjusts therapy pressure during sleep to help patients overcome episodes of sleep disordered breathing. It weighs less than one pound and is compatible with any CPAP mask. Transcend Auto can be used with the new Transcend Heated Humidifier and all of the innovative Transcend accessories including the Transcend portable batteries and solar battery charger. At home or on the road, Transcend products are designed to fit the lifestyle needs of today’s active CPAP users.

Clarence Johnson, CEO and president of Somnetics International, Inc., said “The Transcend Auto is a significant expansion for the innovative Transcend product line and demonstrates our commitment to designing sleep apnea devices that meet the lifestyle needs of active patients. Transcend is the only therapy system of its kind that is this small, lightweight and portable. Transcend is a great PAP device for use every day at home, and it’s very convenient for travel. Our objective is to design sleep apnea devices that meet the lifestyle needs of active patients.”

Every year more than 18 million people are diagnosed with Obstructive Sleep Apnea in the U.S. with more than 40 million suffering from a chronic sleep disorder, according to the National Institutes of Health. Sleep apnea is a chronic condition that requires long-term management and for which continuous positive airway pressure (CPAP) or APAP devices are prescribed to provide constant, mild air pressure that keeps the airways open to provide a restful night of sleep.

Somnetics International, Inc. sells its products through an established network of distributors and direct sales representatives serving markets across the U.S. and in key markets around the world.

For information about the new Transcend Auto and accessories and all of the innovative Transcend products visit http://www.mytranscend.com or call 877-621-9626.

About Somnetics International, Inc.
Somnetics International, Inc. is a privately-held medical device company based in Minneapolis, Minn. It is an emerging leader in customer-driven design, development and production of respiratory medical devices to treat sleep apnea and related issues. Somnetics’ mission is focused on integrating technology, customer input and employee creativity to provide innovative, high quality products that improve quality of life for people with respiratory disorders. Transcend received the Innovation Award at Medtrade in October 2011 and the 2012 Best Practices Award for Product Differentiation in the Sleep Disordered Breathing market from Frost & Sullivan. Somnetics received FDA market clearance for the Transcend CPAP machine in July 2010. Transcend and associated technology is protected by several issued and pending US and foreign patents.

###

Media Contact: Kathleen Crandall 612/327-6336 kathleen(at)crandallcommunications(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kathleen Crandall
Crandall Communications
+1 (612) 327-6336
Email >